Several media outlets covered new research published in Science by University of Utah S.J. Quinney College of Law Associate Professor Jorge Contreras, which proposes universities holding CRISPR patents open their licenses to broader segments of the biopharma industry —a change that could potentially lead to important discoveries for human health and medicine. 
Contreras, along with co-author Jacob S. Sherkow of New York Law School, critiques the current “surrogate” licensing model for biopharma technology licensing and proposes a new model that would broaden the accessibility of the technology to others.
Outlets including The Los Angeles Times, BBC (at 18:00 to 22:30), Forbes, Bloomberg, Popular Science, Chemical and Engineering News, Mercury News, Forbes, and STAT News covered the findings and also developments in a court case involving CRISPR patents.